DCPS

Across TCGA pan-cancer cohorts, DCPS mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated DCPS data layer compared with 24 for mass-spec protein and 7 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher DCPS mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated DCPS expression acts as an unfavorable survival marker, although some lineages such as PDAC and LUAD show a favorable association.

PDAC, LUAD, and UCEC are the cancer types where DCPS mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Quartile	All	0.880	0.679	<.001	47	view →
LUAD	DFS	Tertile	All	0.781	0.470	.003	21	view →
UCEC	DFS	Median	II,III,IV	0.826	1.000	.047	2	view →
HNSC	OS	Median	IV	0.605	0.823	.029	2	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

DCPS–PDAC (DFS)

Open the PDAC breakdown →